Oral Resveratrol Reduces Neuronal Damage in a Model of Multiple Sclerosis

Abstract

These studies demonstrate that SRT501 attenuates neuronal damage and neurological dysfunction in EAE by a mechanism involving SIRT1 activation. SIRT1 activators are a potential oral therapy in MS.